Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease

Megan M Smith1, James A Mills, Eric A Epping

  • 1Carver College of Medicine, University of Iowa, Iowa City, IA, USA.

Neuropsychology
|August 1, 2012
PubMed

Insights

Depression severity is linked to worse cognitive function in individuals with prodromal Huntington disease (HD). Addressing depression may improve cognitive impairment in HD patients.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Huntington disease (HD) is a neurodegenerative disorder.
  • Depression is common in HD and may worsen cognitive deficits.
  • Research on depression's impact on cognition in prodromal HD is limited.

Purpose of the Study:

  • To investigate the relationship between depressive symptom severity and cognitive performance in individuals with prodromal HD.
  • To examine executive functioning, learning/memory, and attention in relation to depression levels.

Main Methods:

  • 814 prodromal HD participants and 230 gene-negative controls completed neuropsychological tests.
  • The Beck Depression Inventory-II (BDI-II) assessed depression severity.
  • Participants were categorized into minimal, mild, moderate, and severe depression groups based on BDI-II scores.

Main Results:

  • Moderate and severe depression groups performed worse on tests of executive functioning (SDMT, Trails B, Stroop interference) and learning/memory (HVLT-R Immediate Recall) compared to minimal and mild groups.
  • Depression severity and gene status significantly predicted cognitive performance.
  • Gene status had a greater impact on memory and Trails B performance, while depression and gene status had comparable contributions to other cognitive tests.

Conclusions:

  • Depressive symptom severity is associated with poorer cognitive performance in prodromal HD.
  • Depression may be a treatable factor contributing to cognitive impairment in this population.
  • Findings suggest potential therapeutic targets for cognitive deficits in HD.
Abstract

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...